NextPoint Therapeutics
About:
NextPoint Therapeutics is a clinical-stage biotechnology company that develops therapeutics to treat cancer patients.
Website: https://nextpointtx.com/
Twitter/X: NextPointTX
Top Investors: Invus, Catalio Capital Management, Leaps by Bayer, MPM Capital, Sanofi Ventures
Description:
NextPoint Therapeutics is a clinical-stage biotechnology company that develops therapeutics to treat cancer patients. The company offers immunotherapies for a validated checkpoint axis that is independent of PD-1/L1 and modulates both adaptive and innate immune systems to find and destroy cancer cells. It advances therapeutic approaches utilizing the unique upregulation of HHLA2 in cancer as an anchor for tumor-targeting therapeutic modalities.
$123M
$1M to $10M
Cambridge, Massachusetts, United States
2020-01-01
info(AT)nextpointtx.com
Gordon Freeman, Xingxing Zang
51-100
2024-02-14
Private
© 2025 bioDAO.ai